NGM Biopharmaceuticals, Inc. Cash on Hand 2019-2023 | NGM
NGM Biopharmaceuticals, Inc. cash on hand from 2019 to 2023. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
| NGM Biopharmaceuticals, Inc. Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2023 | $147 |
| 2022 | $271 |
| 2021 | $366 |
| 2020 | $295 |
| 2019 | $345 |
| 2018 | $207 |
| 2017 | $ |
| NGM Biopharmaceuticals, Inc. Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2023-12-31 | $147 |
| 2023-09-30 | $169 |
| 2023-06-30 | $195 |
| 2023-03-31 | $233 |
| 2022-12-31 | $271 |
| 2022-09-30 | $300 |
| 2022-06-30 | $298 |
| 2022-03-31 | $330 |
| 2021-12-31 | $366 |
| 2021-09-30 | $383 |
| 2021-06-30 | $391 |
| 2021-03-31 | $413 |
| 2020-12-31 | $295 |
| 2020-09-30 | $288 |
| 2020-06-30 | $312 |
| 2020-03-31 | $328 |
| 2019-12-31 | $345 |
| 2019-09-30 | $357 |
| 2019-06-30 | $362 |
| 2019-03-31 | $193 |
| 2018-12-31 | $207 |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
